| Total (n = 134) | Open (n = 50) | VATS (n = 84) | p value |
---|---|---|---|---|
Preoperative AFP (ng/ml) | 18.9 (1.1–12,000.0) | 34.9 (1.1–7330.0) | 9.9 (1.2–12000.0) | 0.155 |
Postoperative AFP (ng/ml) | 10.6 (0–28,200.0) | 11.8 (0–28,200.0) | 8.8 (0–18,800.0) | 0.193 |
Local recurrence | 73 (50.3%) | 33 (66.0%) | 40 (47.6%) | 0.112 |
Progression of local disease | 16 (11.0%) | 5 (10.0%) | 11 (13.1%) | |
Laterality | Â | Â | Â | 0.039 |
 Bilateral | 30 (22.4%) | 16 (32.0%) | 14 (16.7%) | |
 Unilateral | 104 (77.6%) | 34 (68.0%) | 70 (83.3%) | |
Number of metastasis | 1.8 ± 1.4 | 2.2 ± 1.9 | 1.5 ± 0.9 | 0.009 |
Size (mm) | 14.9 ± 9.4 | 16.4 ± 8.1 | 14.0 ± 10.0 | 0.143 |
Extent of resection | Â | Â | Â | 0.001 |
 Wedge resection | 104 (77.6%) | 30 (60.0%) | 74 (88.1%) | |
 Segmentectomy/lobectomy | 30 (22.4%) | 20 (40.0%) | 10 (11.9%) | |
Hospital stay (days) | 6.4 ± 4.2 | 7.9 ± 4.0 | 5.4 ± 4.1 | 0.001 |
Complications | 6 (4.5%) | 4 (8.0%) | 2 (2.4%) | 0.195 |
DFI from HCC (months) | 22.6 ± 17.2 | 21.8 ± 16.4 | 23.1 ± 17.7 | 0.666 |
DFI from PM (months) | 22.3 ± 39.4 | 22.6 ± 43.7 | 22.2 ± 36.9 | 0.945 |
Overall survival time (months) | 52.1 ± 41.0 | 56.4 ± 46.6 | 49.5 ± 37.3 | 0.377 |